Regulation and function of epithelial secreted phospholipase A2 group X in asthma

Teal S. Hallstrand, Ying Lai, William A. Altemeier, Cara L. Appel, Brian Johnson, Charles W. Frevert, Kelly L. Hudkins, James G. Bollinger, Prescott G. Woodruff, Dallas M. Hyde, William R. Henderson, Michael H. Gelb

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Rationale: Indirect airway hyperresponsiveness (AHR) is a fundamental feature of asthma that is manifest as exercise-induced bronchoconstriction (EIB). Secreted phospholipase A2 group X (sPLA2-X) plays a key role in regulating eicosanoid formation and the development of inflammation and AHR in murine models. Objectives: We sought to examine sPLA2-X in the airway epithelium and airway wall of patients with asthma, the relationship to AHR in humans, and the regulation and function of sPLA 2-X within the epithelium. Methods:We precisely phenotyped 34 patients with asthma (19 with and15 without EIB)and10 normal control subjects to examinein vivo differences in epithelial gene expression, quantitativemorphometry of endobronchial biopsies, and levels of secreted protein. The regulation of sPLA2-X gene (PLA2G10) expression was examined in primary airway epithelial cell cultures. The function of epithelial sPLA2-X in eicosanoid formation was examined using PLA2 inhibitors and murine tracheal epithelial cells with PlA 2g10 deletion. Measurements and Main Results: We found that sPLA 2-X protein is increased in the airways of patients with asthma and that epithelial-derived sPLA2-X may be increased in association with indirect AHR. The expression of sPLA2-X increases during in vitro epithelial differentiation; is regulated by inflammatory signals including tumor necrosis factor, IL-13, and IL-17; and is both secreted from the epitheliumand directly participates in the release of arachidonic acid by epithelial cells. Conclusions: These data reveal a relationship between epithelialderived sPLA2-X and indirect AHR in asthma and that sPLA2-X serves as an epithelial regulator of inflammatory eicosanoid formation. Therapies targeting epithelial sPLA2-X may be useful in asthma.

Original languageEnglish (US)
Pages (from-to)42-50
Number of pages9
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume188
Issue number1
DOIs
StatePublished - Jul 1 2013

Fingerprint

Secretory Phospholipase A2
Asthma
Group X Phospholipases A2
Eicosanoids
Bronchoconstriction
Epithelial Cells
Epithelium
Exercise
Gene Expression
Interleukin-13
Interleukin-17
Arachidonic Acid
Proteins
Cell Culture Techniques
Tumor Necrosis Factor-alpha
Inflammation
Biopsy

Keywords

  • Airway hyperresponsiveness
  • Asthma
  • Eicosanoid
  • Epithelial cell
  • Secretory phospholipase A

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Hallstrand, T. S., Lai, Y., Altemeier, W. A., Appel, C. L., Johnson, B., Frevert, C. W., ... Gelb, M. H. (2013). Regulation and function of epithelial secreted phospholipase A2 group X in asthma. American Journal of Respiratory and Critical Care Medicine, 188(1), 42-50. https://doi.org/10.1164/rccm.201301-0084OC

Regulation and function of epithelial secreted phospholipase A2 group X in asthma. / Hallstrand, Teal S.; Lai, Ying; Altemeier, William A.; Appel, Cara L.; Johnson, Brian; Frevert, Charles W.; Hudkins, Kelly L.; Bollinger, James G.; Woodruff, Prescott G.; Hyde, Dallas M.; Henderson, William R.; Gelb, Michael H.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 188, No. 1, 01.07.2013, p. 42-50.

Research output: Contribution to journalArticle

Hallstrand, TS, Lai, Y, Altemeier, WA, Appel, CL, Johnson, B, Frevert, CW, Hudkins, KL, Bollinger, JG, Woodruff, PG, Hyde, DM, Henderson, WR & Gelb, MH 2013, 'Regulation and function of epithelial secreted phospholipase A2 group X in asthma', American Journal of Respiratory and Critical Care Medicine, vol. 188, no. 1, pp. 42-50. https://doi.org/10.1164/rccm.201301-0084OC
Hallstrand, Teal S. ; Lai, Ying ; Altemeier, William A. ; Appel, Cara L. ; Johnson, Brian ; Frevert, Charles W. ; Hudkins, Kelly L. ; Bollinger, James G. ; Woodruff, Prescott G. ; Hyde, Dallas M. ; Henderson, William R. ; Gelb, Michael H. / Regulation and function of epithelial secreted phospholipase A2 group X in asthma. In: American Journal of Respiratory and Critical Care Medicine. 2013 ; Vol. 188, No. 1. pp. 42-50.
@article{4d7ca1647f894f96b45f17df94d25a1b,
title = "Regulation and function of epithelial secreted phospholipase A2 group X in asthma",
abstract = "Rationale: Indirect airway hyperresponsiveness (AHR) is a fundamental feature of asthma that is manifest as exercise-induced bronchoconstriction (EIB). Secreted phospholipase A2 group X (sPLA2-X) plays a key role in regulating eicosanoid formation and the development of inflammation and AHR in murine models. Objectives: We sought to examine sPLA2-X in the airway epithelium and airway wall of patients with asthma, the relationship to AHR in humans, and the regulation and function of sPLA 2-X within the epithelium. Methods:We precisely phenotyped 34 patients with asthma (19 with and15 without EIB)and10 normal control subjects to examinein vivo differences in epithelial gene expression, quantitativemorphometry of endobronchial biopsies, and levels of secreted protein. The regulation of sPLA2-X gene (PLA2G10) expression was examined in primary airway epithelial cell cultures. The function of epithelial sPLA2-X in eicosanoid formation was examined using PLA2 inhibitors and murine tracheal epithelial cells with PlA 2g10 deletion. Measurements and Main Results: We found that sPLA 2-X protein is increased in the airways of patients with asthma and that epithelial-derived sPLA2-X may be increased in association with indirect AHR. The expression of sPLA2-X increases during in vitro epithelial differentiation; is regulated by inflammatory signals including tumor necrosis factor, IL-13, and IL-17; and is both secreted from the epitheliumand directly participates in the release of arachidonic acid by epithelial cells. Conclusions: These data reveal a relationship between epithelialderived sPLA2-X and indirect AHR in asthma and that sPLA2-X serves as an epithelial regulator of inflammatory eicosanoid formation. Therapies targeting epithelial sPLA2-X may be useful in asthma.",
keywords = "Airway hyperresponsiveness, Asthma, Eicosanoid, Epithelial cell, Secretory phospholipase A",
author = "Hallstrand, {Teal S.} and Ying Lai and Altemeier, {William A.} and Appel, {Cara L.} and Brian Johnson and Frevert, {Charles W.} and Hudkins, {Kelly L.} and Bollinger, {James G.} and Woodruff, {Prescott G.} and Hyde, {Dallas M.} and Henderson, {William R.} and Gelb, {Michael H.}",
year = "2013",
month = "7",
day = "1",
doi = "10.1164/rccm.201301-0084OC",
language = "English (US)",
volume = "188",
pages = "42--50",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "1",

}

TY - JOUR

T1 - Regulation and function of epithelial secreted phospholipase A2 group X in asthma

AU - Hallstrand, Teal S.

AU - Lai, Ying

AU - Altemeier, William A.

AU - Appel, Cara L.

AU - Johnson, Brian

AU - Frevert, Charles W.

AU - Hudkins, Kelly L.

AU - Bollinger, James G.

AU - Woodruff, Prescott G.

AU - Hyde, Dallas M.

AU - Henderson, William R.

AU - Gelb, Michael H.

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Rationale: Indirect airway hyperresponsiveness (AHR) is a fundamental feature of asthma that is manifest as exercise-induced bronchoconstriction (EIB). Secreted phospholipase A2 group X (sPLA2-X) plays a key role in regulating eicosanoid formation and the development of inflammation and AHR in murine models. Objectives: We sought to examine sPLA2-X in the airway epithelium and airway wall of patients with asthma, the relationship to AHR in humans, and the regulation and function of sPLA 2-X within the epithelium. Methods:We precisely phenotyped 34 patients with asthma (19 with and15 without EIB)and10 normal control subjects to examinein vivo differences in epithelial gene expression, quantitativemorphometry of endobronchial biopsies, and levels of secreted protein. The regulation of sPLA2-X gene (PLA2G10) expression was examined in primary airway epithelial cell cultures. The function of epithelial sPLA2-X in eicosanoid formation was examined using PLA2 inhibitors and murine tracheal epithelial cells with PlA 2g10 deletion. Measurements and Main Results: We found that sPLA 2-X protein is increased in the airways of patients with asthma and that epithelial-derived sPLA2-X may be increased in association with indirect AHR. The expression of sPLA2-X increases during in vitro epithelial differentiation; is regulated by inflammatory signals including tumor necrosis factor, IL-13, and IL-17; and is both secreted from the epitheliumand directly participates in the release of arachidonic acid by epithelial cells. Conclusions: These data reveal a relationship between epithelialderived sPLA2-X and indirect AHR in asthma and that sPLA2-X serves as an epithelial regulator of inflammatory eicosanoid formation. Therapies targeting epithelial sPLA2-X may be useful in asthma.

AB - Rationale: Indirect airway hyperresponsiveness (AHR) is a fundamental feature of asthma that is manifest as exercise-induced bronchoconstriction (EIB). Secreted phospholipase A2 group X (sPLA2-X) plays a key role in regulating eicosanoid formation and the development of inflammation and AHR in murine models. Objectives: We sought to examine sPLA2-X in the airway epithelium and airway wall of patients with asthma, the relationship to AHR in humans, and the regulation and function of sPLA 2-X within the epithelium. Methods:We precisely phenotyped 34 patients with asthma (19 with and15 without EIB)and10 normal control subjects to examinein vivo differences in epithelial gene expression, quantitativemorphometry of endobronchial biopsies, and levels of secreted protein. The regulation of sPLA2-X gene (PLA2G10) expression was examined in primary airway epithelial cell cultures. The function of epithelial sPLA2-X in eicosanoid formation was examined using PLA2 inhibitors and murine tracheal epithelial cells with PlA 2g10 deletion. Measurements and Main Results: We found that sPLA 2-X protein is increased in the airways of patients with asthma and that epithelial-derived sPLA2-X may be increased in association with indirect AHR. The expression of sPLA2-X increases during in vitro epithelial differentiation; is regulated by inflammatory signals including tumor necrosis factor, IL-13, and IL-17; and is both secreted from the epitheliumand directly participates in the release of arachidonic acid by epithelial cells. Conclusions: These data reveal a relationship between epithelialderived sPLA2-X and indirect AHR in asthma and that sPLA2-X serves as an epithelial regulator of inflammatory eicosanoid formation. Therapies targeting epithelial sPLA2-X may be useful in asthma.

KW - Airway hyperresponsiveness

KW - Asthma

KW - Eicosanoid

KW - Epithelial cell

KW - Secretory phospholipase A

UR - http://www.scopus.com/inward/record.url?scp=84880147416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880147416&partnerID=8YFLogxK

U2 - 10.1164/rccm.201301-0084OC

DO - 10.1164/rccm.201301-0084OC

M3 - Article

C2 - 23614662

AN - SCOPUS:84880147416

VL - 188

SP - 42

EP - 50

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 1

ER -